The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells
André Fedier(University of Zurich), Daniel Fink(University Hospital of Zurich)
Cited by 37
Related Papers
Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells
|Fertility and Sterility|2010|46
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells
|International Journal of Oncology|2009|10
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
|International Journal of Oncology|2022|9
Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells
|Experimental and Therapeutic Medicine|2013|8